Bonsel GJ - Search Results

1

The PROTON study: profiles of blood product transfusion recipients in the Netherlands.

Borkent-Raven BA, Janssen MP, van der Poel CL, Schaasberg WP, Bonsel GJ, van Hout BA. Borkent-Raven BA, et al. Among authors: bonsel gj. Vox Sang. 2010 Jul 1;99(1):54-64. doi: 10.1111/j.1423-0410.2010.01312.x. Epub 2010 Feb 24. Vox Sang. 2010. PMID: 20202179

2

Assessing the benefits of transplant services.

Michel BC, Van Hout BA, Bonsel GJ. Michel BC, et al. Among authors: bonsel gj. Baillieres Clin Gastroenterol. 1994 Sep;8(3):411-23. doi: 10.1016/0950-3528(94)90028-0. Baillieres Clin Gastroenterol. 1994. PMID: 8000090 Review.

3

Heart transplantation in the Netherlands; costs, effects and scenarios.

van Hout B, Bonsel G, Habbema D, van der Maas P, de Charro F. van Hout B, et al. J Health Econ. 1993 Apr;12(1):73-93. doi: 10.1016/0167-6296(93)90041-c. J Health Econ. 1993. PMID: 10126491 Review.

4

Effects of ACE inhibitors on heart failure in The Netherlands: a pharmacoeconomic model.

van Hout BA, Wielink G, Bonsel GJ, Rutten FF. van Hout BA, et al. Among authors: bonsel gj. Pharmacoeconomics. 1993 May;3(5):387-97. doi: 10.2165/00019053-199303050-00006. Pharmacoeconomics. 1993. PMID: 10146889

5

Costs and benefits of bacterial culturing and pathogen reduction in the Netherlands.

Janssen MP, van der Poel CL, Buskens E, Bonneux L, Bonsel GJ, van Hout BA. Janssen MP, et al. Among authors: bonsel gj. Transfusion. 2006 Jun;46(6):956-65. doi: 10.1111/j.1537-2995.2006.00828.x. Transfusion. 2006. PMID: 16734812 Free article.

6

Monitoring viral incidence rates: tools for the implementation of European Union regulations.

Janssen MP, Cator EA, van der Poel CL, Schaasberg WP, Bonsel GJ, van Hout BA. Janssen MP, et al. Among authors: bonsel gj. Vox Sang. 2009 May;96(4):298-308. doi: 10.1111/j.1423-0410.2009.01166.x. Epub 2009 Feb 18. Vox Sang. 2009. PMID: 19228368

7

Cost-effectiveness of additional hepatitis B virus nucleic acid testing of individual donations or minipools of six donations in the Netherlands.

Borkent-Raven BA, Janssen MP, van der Poel CL, de Wit GA, Bonsel GJ, van Hout BA. Borkent-Raven BA, et al. Among authors: bonsel gj. Transfusion. 2009 Feb;49(2):311-9. doi: 10.1111/j.1537-2995.2008.01968.x. Transfusion. 2009. PMID: 19389213

8

Survival after transfusion in the Netherlands.

Borkent-Raven BA, Janssen MP, van der Poel CL, Schaasberg WP, Bonsel GJ, van Hout BA. Borkent-Raven BA, et al. Among authors: bonsel gj. Vox Sang. 2011 Feb;100(2):196-203. doi: 10.1111/j.1423-0410.2010.01378.x. Epub 2010 Aug 18. Vox Sang. 2011. PMID: 20726957

9

Cost-effectiveness of additional blood screening tests in the Netherlands.

Borkent-Raven BA, Janssen MP, van der Poel CL, Bonsel GJ, van Hout BA. Borkent-Raven BA, et al. Among authors: bonsel gj. Transfusion. 2012 Mar;52(3):478-88. doi: 10.1111/j.1537-2995.2011.03319.x. Epub 2011 Aug 31. Transfusion. 2012. PMID: 21880046

10

Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.

Koelewijn JM, Vrijkotte TG, van der Schoot CE, Bonsel GJ, de Haas M. Koelewijn JM, et al. Among authors: bonsel gj. Transfusion. 2008 May;48(5):941-52. doi: 10.1111/j.1537-2995.2007.01625.x. Epub 2008 Feb 1. Transfusion. 2008. PMID: 18248570

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters